Drawing for Serial No. 76455103

USPTO serial 76455103

Serial No. 76455103

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SMITH, BRIDGETT G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with Serial No. 76455103?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

J. Georg Seka

J GEORG SEKA TOWNSEND AND TOWNSEND AND CREW LLPTWO EMBARCADERO CTR 8TH FLSAN FRANCISCO, CA 94111-3834UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary products for supporting the healing-in process of implants, for use on inflammations and for use on degenerated cells of body tissue; dietary supplements; food for medically restricted diets; baby food; medical plasters; wound dressings; burn dressings; surgical dressings; material for filling teeth, and dental impression materials; bone cement for orthopedic surgery; all-purpose disinfectants; preparations for destroying vermin; fungicides for agricultural and domestic use; and herbicides for agricultural and domestic useACTIVE—
010Surgical, medical, dental and veterinary instruments or apparatus for placing or for preparing the placement of implants in body tissue; prostheses, namely hip joint prostheses and hip joint shafts; endoprostheses for the hip, spine, elbow and knee; artificial limbs and eyes; suture materials; prostheses, endoprostheses, vascular prostheses, ureteroprostheses and their parts, in particular shafts and spherical heads; implants, in particular joint implants and implants covered with coating materials; dental and jaw implants, artificial teeth and dentures as well as tooth pins; artificial jaws; coronary and vascular implants, in particular stents; spinal column implants; artificial joints, ligaments, tendons and artificial heart valves as well as flexible lines for medical purposes; measurement apparatus, instruments and tools for the implantation of prostheses and parts of prostheses and also for the operative treatment of fractures; templates for orthopedic purposes; fixators, plates, bone screws and bone nails, pedicle screws, expansion screws, rasps, milling cutters, drilling jigs, hammering instruments and marking jigs as well as medullary space blockers; medical diagnostic apparatus, namely tension measuring devices for ligaments, and navigation apparatus for mapping of body structure; analytical apparatus for preparing the placement of implants in body tissue, and blood pressure measuring apparatus; tools for the contouring and polishing of teeth and artificial teeth; cutting and grinding discs for dental applications; nails, rails, saws and probes for medical purposes; apparatus for endoscopy and for arthroscopy and also their parts; gastroscopes; defibrillators and heart pacemakers as well as their associated electrodes, ablation apparatus and heart wires; pumps for medical purposes, namely blood pumps and dialysis pumps; and lasers for medical purposesACTIVE—
041Educational services, namely conducting classes, seminars, workshops and conferences in the fields of medicine and orthopedic surgery; training services in the fields of medicine and orthopedic surgery; organizing community sport and cultural events; and training doctors and medical personnel regarding operative techniques and the use of medical and technical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 12, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 9, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 20, 20031.BDSec. 1(B) CLAIM DELETED—
Aug 14, 2003CFITCASE FILE IN TICRS—
Jul 24, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 24, 2003MAILPAPER RECEIVED—
Mar 7, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 3, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance